Prelude Capital Management, LLC Ikena Oncology, Inc. Transaction History
Prelude Capital Management, LLC
- $1.57 Billion
- Q3 2024
A detailed history of Prelude Capital Management, LLC transactions in Ikena Oncology, Inc. stock. As of the latest transaction made, Prelude Capital Management, LLC holds 50,638 shares of IKNA stock, worth $72,412. This represents 0.01% of its overall portfolio holdings.
Number of Shares
50,638
Previous 50,638
-0.0%
Holding current value
$72,412
Previous $87,000
-0.0%
% of portfolio
0.01%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding IKNA
# of Institutions
60Shares Held
30.4MCall Options Held
0Put Options Held
0-
Atlas Venture Life Science Advisors, LLC5.02MShares$7.18 Million1.07% of portfolio
-
Bvf Inc San Francisco, CA4.77MShares$6.82 Million0.26% of portfolio
-
Blue Owl Capital Holdings LP New York, NY4.09MShares$5.85 Million2.33% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.54MShares$5.06 Million0.14% of portfolio
-
Omega Fund Management, LLC Boston, MA2.25MShares$3.22 Million5.77% of portfolio
About Ikena Oncology, Inc.
- Ticker IKNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,257,500
- Market Cap $51.8M
- Description
- Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcription factor in the Hippo signaling pathway. I...